DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20220528
Published: 2022-02-25

Peripheral artery disease in patient with end-stage renal disease on regular hemodialysis: a case report

I. Made A. Chandra, I. Made L. Aryana

Abstract


Patients with end-stage renal disease (ESRD) had a higher risk of developing cardiovascular disease, including peripheral artery disease (PAD). The presence of PAD in hemodialysis patients leads to an increase in the incidence of amputation and mortality. However, early diagnosis of PAD in hemodialysis patients is still challenging. Clinical manifestation of PAD in ESRD patients is often atypical manifestations and present in severe manifestations. We reported a case of PAD in the right leg of a 54-year-old woman with end-stage renal disease (ESRD) on regular hemodialysis with comorbid diabetes mellitus and hypertension. Ankle-brachial index (ABI) of the right leg was 0.82 and the result of echo-Doppler supported the presence of PAD in the right distal femoral artery. Then, the patient was treated with antiplatelet therapy, cilostazol, and other medication to control comorbidities. The pain was partly relieved after treatment and the patient was referred to a tertiary hospital for further diagnosis and management. Endocrine and biochemical abnormalities lead to a higher prevalence of PAD in ESRD patients on routine hemodialysis. The non-invasive approach on PAD in ESRD patients has an advantage in improving patients’ outcomes if the diagnosis is established in the earlier stage.


Keywords


Peripheral artery disease, End-stage renal disease, Hemodialysis, Cilostazol

Full Text:

PDF

References


Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Articles Global , regional , and national prevalence and risk factors for peripheral artery disease in 2015 : an updated systematic review and analysis. Lancet Glob Heal. 2019;7(8):1020-30.

Tranche-iparraguirre S, Marín-iranzo R, Sanmamed RF, Riesgo-garcía A, Hevia-rodríguez E, García-casas JB. Peripheral arterial disease and kidney failure : a frequent association. Nefrologia. 2012;32(3):313-20.

Lee C, Wu C, Chou L, Shen S, Chiang S, Jen P. Peripheral artery disease in peritoneal dialysis and hemodialysis patients : single-center retrospective study in Taiwan. BMC Nephrol. 2012;13(100):1-8.

Johansen KL, Garimella PS, Hicks CW, Kalra PA, Kelly DM, Martens S, et al. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidey Int. 2021;100:35-48.

Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med. 2019;24(3):251-60.

Garimella PS, Hirsch AT. Peripheral Artery Disease and Chronic Kidney Disease: Clinical Synergy to Improve Outcomes. Adv Chronic Kidney Dis. 2014;21(6):460-71.

Matsuzawa R, Aoyama N, Yoshida A. Clinical Characteristics of Patients on Hemodialysis With Peripheral Arterial Disease. Angiology. 2015;1-7.

Radislav RA, Dimkovi NB, Trajkovi GŽ, Risti BS, Jankovi AN, Duri PS, et al. Prevalence , clinical characteristics , and predictors of peripheral arterial disease in hemodialysis patients : a cross-sectional study. BMC Nephrol. 2019;20(281):1-9.

Serra R, Bracale UM, Ielapi N, Guercio L Del, Donata M, Taranto D, et al. The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization. Int J Gen Med. 2021;14:3749-59.

Hsu Y, Sung F, Muo C, Chuang S, Hsu CY, Hsu C. Increased risk of developing peripheral artery disease in hemodialysis patients receiving statin treatments : a population- based cohort study in Taiwan. Nephrol Dial Transpl. 2020;35:1753-60.

Okamoto S, Iida O, Mano T. Current Perspective on Hemodialysis Patients with Peripheral Artery Disease. Ann Vasc Dis. 2017;10(2):88-91.

Lin C-S, Chen S-J, Sung C-C, Lin C-L, Lin S-H, Cheng S-M, et al. Hemodialysis Is Associated With Increased Peripheral Artery Renal Disease. Medicine (Baltimore). 2015;94(28):1-7.

Levine SD. Peripheral Arterial Disease : A Case Report From the Henry Ford Hospital. J Clincal Exerc Physiol. 2018;7(1):15-21.

Li J, Yan M, Qin J, Liu J, Wen R. Severe peripheral arterial diseases in hemodialysis patient. Medicine (Baltimore). 2020;99(4):1-4.

Firnhaber JM, Ed MA, Carolina N. Lower Extremity Peripheral Artery Disease : Diagnosis and Treatment. Am Fam Physician. 2019;99(6):361-9.

Kim ESH, Sharma AM, Scissons R, Dawson D, Eberhardt RT, Gerhard-Herman M, et al. Interpretation of Peripheral Arterial and Venous Doppler Waveforms: A Consensus Statement From the Society for Vascular Medicine and Society for Vascular Ultrasound. J Vasc Ultrasound. 2020;44(3):118-43.

Pollak AW, Norton PT, Kramer CM. Multimodality imaging of lower extremity peripheral arterial disease current role and future directions. Circ Cardiovasc Imaging. 2012;5(6):797-807.

Patel VI, Mukhopadhyay S, Guest JM, Conrad MF, Watkins MT, Kwolek CJ, et al. Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention. J Vasc Surg. 2014;59(2):368-75.

Real J, Serna MC, Giner-Soriano M, Forés R, Pera G, Ribes E, et al. Safety of cilostazol in peripheral artery disease: A cohort from a primary healthcare electronic database. BMC Cardiovasc Disord. 2018;18(1):1-7.

Baigent C, Landray M, Reith C, Dasgupta T, Emberson J, Herrington W, et al. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J. 2010;160(5):785-94.